Introduction 1) I would argue that the burden and economic impact of breast cancer diagnoses is not particularly challenging for developed countries, but rather much more important for low-and middleincome countries, that have both the highest burden of disease as well as the greater financial impact.
It would be useful if the authors mention that the usage status of ICD9 and ICD10 codes among each administrative database or/and country. 5.
Page 5; line9-1: The primary goal is inconsistent with the conclusions. If the authors had determined the algorithm that accurately identify the breast cancer cases, they should exhibit the algorithm. 6. Page 7; line21-23: How did the authors detect that the study sample was extracted from general population? For example, if a study conducted using administrative database and reference standard from single medical institution, the generalizability seems low. 7.
Page 9-; Result section, Page 13-; Discussion section: In connection with the question6, the generalizability of each study should be mentioned in result and discussion sections. The authors have already shown the information in the Table1, but there are no comprehensive summary and no discussions. I bet that generalizability is important for the authors because they applied it as one of the inclusion criteria of this study. In addition, researchers in this field must be interested in what kind of data sources (e.g., type of databases, type of reference standards, extracted from single institution or multiple institutions) are appropriate to use for a validation study. 8.
Page 11; line17-31; Table 4 : The classification of algorithm in Table 4 seems not appropriate. Of the algorithms in the table 4, part of the algorithms included surgical procedures. The authors divided the algorithm into two categories according to treatment (1. surgical procedures, 2. chemo or radiation therapy). 9.
Page 11; line52-: It would be useful if the authors mentioned types of data which were used in each of the other 19 studies. Did the 19 studies used only inpatients data or combination of inpatients data and the other data? 10.
Page 12; line10-42: In this section, somehow almost reference papers are omitted. Relevant papers should be exactly cited. 11.
Page13; line24-8:"The addition of other fields such as surgical procedures, outpatient data and physician claims may improve the accuracy results but depend on the accuracy measure used." I don't believe that the outpatient data and physician claims improved the accuracy of the results because each of the PPVs was too low. What led you to the comments that these data may increase the accuracy?
Major comments: 1. Page 14; line41-: It would be more reader friendly if the authors explain "Part B". Not all readers are familiar with administrative databases.
1.
The title, abstract and the study objective suggest this systematic review include all breast cancer cases. It was only in the method section that the author mentioned the focus was on the primary diagnosis of breast cancer, instead of metastatic or recurring cancer. It is unclear to the reviewer that primary diagnosis of breast cancer was part of the inclusion/exclusion criteria or search strategy. Additionally, not including metastatic breast cancer was stated as a study limitation on page 15-it would not be a limitation if metastatic breast cancer was outside the scope of this study. This needs more clarifications.
2.
My understanding of primary breast cancer is the tumour that origins from the breast tissues. A woman may have more than one primary breast cancers in her life. Was second primary breast cancer included in this study?
3.
The data fields extracted from the included studies were clearly outlined on page 8. Since this study is focused on breast cancer, data extraction on 'the disease of interest' is unnecessary. Or was this data extraction field used to flag 'invasive' vs. 'In Situ' breast cancers?
4.
The author mentioned that the literature search was conducted from the inception of each database. It would be useful to also provide the end date of the search.
5.
Authors appraised the quality of eligible studies according to the STARD criteria. How was this quality assessment result used to inform the final conclusion? 6. Table 1 provides a nice summary of characteristics of included studies. The ICD codes, data source and algorithms were clearly outlined. I noticed for some studies, the algorithm was simply 'New Cases of Breast Cancer' (McBean 1994 ). This does not look like an algorithm. How was a new case identified? A typical breast cancer patient needs multiple physician visits before a cancer is diagnosed and each visit would generate a diagnosis code (or a code for suspected diagnosis). How did McBean determine which visit should be used to retrieve the ICD code and from which data source? Was the diagnostic code in the first position (main diagnosis) or in any position? Also, I did not see the number occurrence specified in any algorithm listed in Table 1 . Did all studies only look at occurrence of one ICD-9/10 breast cancer diagnosis code for each patient? More clarifications would be helpful.
7.
It is challenging to synthesize the findings due to the variation in study setting. According the published Protocol (Abraha 2016), the author had planned to aggregate validation statistics by country of origin, type of breast cancers (incident vs. prevalent or invasive vs. in situ), data source and ICD coding system (ICD-9/10). I wonder why this planned analysis was not conducted.
8.
I am curious in the role of coding practices in determining the accuracy of ICD-based algorithms for breast cancer case identification. Despite the human error in data entry (one may assume it is non-differential misclassification if the error is at random), the variation in coder's knowledge and experience may bias the study. Perhaps this should be addressed in the discussion section or as a study limitation.
9.
Lastly, there are a few typographic errors in this paper that need to be corrected. a) Line 49 on page 11, the table shows 91% in both primary positions while it was written as 61% and 91% in the text. Also Line 49, the table should be eTable 1. b) in eTable 2 on page 35, the specificity was 100 (100 to 100591) for the algorithm by Warren 1999 using physician data. This needs to be verified.
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GENERAL COMMENTS
This manuscript considers the literature on diagnostic accuracy of various algorithms in identifying breast cancer cases in administrative data. The authors have done well in applying sound methods in the systematic review of the relevant literature. They report the diagnostic accuracy measures for various algorithms applied to different administrative databases. The authors do well in reporting the diagnostic accuracy measures and explain some of the within study heterogeneity due to differences in algorithms used, but do not clearly consider the heterogeneity in diagnostic accuracy between administrative databases (between study heterogeneity). This is an important aspect that is omitted from the analysis and discussion. There can be vast differences between the (quality and/or) entry of information into administrative databases as well as the reference standard databases. This might vary by country, by healthcare system/jurisdiction, and over time. It would be important for the authors to consider this aspect in their analysis (whether narratively/descriptively, or quantitatively).
Minor issues:
• The authors should provide explanation of the 'positioning' of breast cancer codes in the administrative databases.
• Minor instances where language/grammar could be improved.
VERSION 1 -AUTHOR RESPONSE
Reviewer: 1 Reviewer Name: Henry Rice Institution and Country: Duke University Medical Center, Durham Please state any competing interests: None declared Please leave your comments for the authors below This report by Abraha et al is a systematic review of the diagnostic accuracy of breast cancer diagnoses using administrative datasets. In itself this is valuable area of study and would be of interest to the readership of your journal. However, in its present form, I have some concerns about this manuscript that limit my enthusiasm for publication. Specifically, I would recommend the following: Abstract; 1) The overall objective is weak, "...to perform the first systematic review of studies...". Simply performing the first systematic review of any topic is not a valuable objective in itself. Rather, for this report the objective should read something along the lines "to define the accuracy of administrative datasets to identify incident diagnoses of breast cancer..." **We thank Dr. Rice for his positive comment on our review. We reworded the objective of our review as follows: "To define the accuracy of administrative datasets to identify diagnoses of breast cancer based on the International Classification of Diseases 9th or 10th revision codes.". Introduction 1) I would argue that the burden and economic impact of breast cancer diagnoses is not particularly challenging for developed countries, but rather much more important for low-and middle-income countries, that have both the highest burden of disease as well as the greater financial impact. **In our sentence, we were referring to the worldwide economic expenditure for cancer that is for the vast majority allocated to developed countries (Lancet. 2017 Feb 25; 389(10071) :847-860. doi: 10.1016/S0140-6736(16)31392-7. Epub 2016 Nov 1.). We reworded the sentence as follows (adding also a reference for the low-and middle-income countries): "The burden of cancer is increasingly growing among populations, and it is associated with major economic expenditure worldwide [1] especially in low and middle income countries [2] .".
2) The sentence "use of these databases allows for more efficient analyses, and unlike randomized trials, their representativeness of routine clinical practice in large populations can provide more generalizable findings" is grammatically unclear. What are the authors comparing administrative datasets to? Randomized trials? Other datasets? **We reworded the sentence as follows: "Generally, these databases gather longitudinal information concerning health resource utilization regarding hospitalizations, outpatient care, and, often, drug prescriptions and vital statistics [14] . In other words, these databases provide a readily available source of "real-world" data on a large population of unselected patients allowing the performance of less expensive and more representative assessment of disease surveillance and outcome research compared to randomized trials [15, 16] .".
3) The sentence "Actually the diagnostic criteria for breast cancer is based on histological examinations and the radiological analyses can contribute for staging" is a bit confusing and does not seem to follow from the previous sentence. Nor do I understand why the authors state the term "Actually" at the beginning...is this to define the role of tissue diagnosis to support ICD diagnosis? **We agree with this comment and we thank Dr. Rice for indicating this point: We reworded the paragraph as follows: "The current International Classification of Diseases, 9th Revision, (ICD-9) codes are 233.0 for breast carcinoma in situ and 174.0 -174.9 for invasive breast cancer whereas the ICD-10 codes are D05.0-D05.9 and C50.0-C50.9, respectively. These codes help to identify subjects that have breast cancer within an administrative healthcare database. Since the clinical diagnosis of breast cancer is based on a combination of clinical and/or instrumental examinations and a pathological assessment [19] , these codes are limited in confirming whether a specific subject within the databases truly has the disease of interest. As a result, researchers have proposed a number of different claim-based algorithms for case identification of breast cancers, such as a combination of healthcare claims data [20] , the use of chemotherapy [21] and the number of medical claims on separate dates [11] . In addition, since patients with metastatic cancer have different prognoses and typically different treatment patterns to those with earlier-stage malignancies, researchers suggest using algorithms to identify patients with metastatic cancer [11, 22] .". Methods 1) I think it would be helpful to expand on the methods-specifically, what criteria did the authors use to confirm the use of a reference standard case definition for breast cancer? Can the authors also expand on this point in the discussion-how are these terms defined, how are the used for coding and extraction from administrative datasets? **We thank Dr. Rice for this interesting comment. The sentences in the inclusion criteria should have been as follows: "(a) the presence of a reference standard (clinical chart, cancer registry or electronic health records), together with the presence of any case definition or algorithm for breast cancer; (b) the presence of at least one test measure (e.g., sensitivity, positive predictive value, etc.);..". In addition, we added the following paragraph in the discussion: "Regarding reference standard, most of the studies used cancer registries and the confirmation of the cancer disease was based on the presence of the corresponding code within the registry. When medical charts were used as a reference standard, the studies reported different types of descriptions to confirm the presence of disease: Fisher et al [39] reported that "accredited records technicians, blinded to the coding in the original records, reviewed the medical records, selected the supportable diagnoses and procedures, and translated them into ICD-9-CM"; in both the studies conducted by Solin et al [48, 49] and in the study by Leung et al [43] , the diagnosis of carcinoma of the breast was confirmed when there was evidence of a histological documentation of "invasive carcinoma of the breast", "intraductal carcinoma (ductal carcinoma in situ) of the breast" or "Paget's disease of the breast.". The paper by Abraha et al. entitled 'Accuracy of administrative databases in detecting breast cancer diagnoses: a systematic review' is an interesting study that systematic reviews of validation studies of breast cancer diagnoses. The authors reviewed studies reporting the accuracy of ICD9/10 codes to identify breast cancer diagnosed in administrative healthcare databases. Two reviewers used STARD criteria to select eligible studies and they screened 21 studies. They found 20 studies considers incident cases of breast cancer, and combination of breast cancer diagnosis and the other procedures or/and treatments enhance the accuracy of algorithm to identify the breast cancer cases. The study was well conducted and the methods are appropriate. The findings will be of interest to medical experts as well as public officials and researchers in this field. However, I recommend several major and minor revision points before the acceptance of this manuscript. **We thank Dr. Sato for his positive comment.
Major comments: 1. Page 2; Line33, Page 9; line 8-17, Figure 1 : I understand that the authors finally selected 21 studies according to the eligibility criteria, PRISMA-P statement, and PRISMA flow diagram. But it is not clear that the reasons why the authors excluded 2888 papers and 25 papers in stages. It would be useful if the authors describe each of the reasons. In addition, the process of the selection seems different from the manuscript and Figure1. When did the authors include the five studies? **We screened 2,929 records on basis of title and abstract. Of these, we excluded 2,888 according to our eligibility criteria (usually, in this phase, it is not necessary to specify the reasons of exclusion), leaving 41 records to examine in full-text. During the phase of title/abstract screening, we identified through reference lists check 5 additional records to examine in full-text, leading the total of records to examine in full-text to 46 (41 + 5). Of the 46 full-texts examined, we finally decided to include in our review 21 articles, excluding 25 articles. We have now added in the diagram the reasons of exclusion of the 25 articles excluded after full-text evaluation. A supplemental file with excluded studies with reasons for exclusion and complete references is now provided.
Page 3; line19-48:
Of five points, the 2-4 points do not seem to be strengths nor limitations, but just results of this study. I believe that there are additional strengths and limitations to 1st and 5th points. **We modified the Strengths and Limitations section as follows:
• Based on a pre-published protocol, this is the first review that systematically addressed the accuracy of administrative databases in identifying subjects with breast cancer.
• We performed a comprehensive electronic databases search complemented with reference check of relevant articles, and we evaluated the quality of reporting of included studies by the STARD checklist.
• We considered only papers written in English and this might have introduced a language bias.
•
The knowledge and experience of the ICD-9/10 coders could have influenced the quality of breast cancer case definition in each study, and consequently the results presented in our review could be biased by this factor.
• Generalizability of validated administrative databases is limited to the context in which they are generated.
Page 4; Line38:
The authors should describe the detail of "reference standard" that used in each validation studies. The "reference standard" is quiet important when a validation study is conducted. Because the reference must be trusted worthy to validate the diagnosis. **In addition to what we have described in the Results and in Table 1 , we have added a paragraph in Discussion reporting the criteria used to validate the diagnosis when medical charts were used: "Regarding reference standard, most of the studies used cancer registries and the confirmation of the cancer disease was based on the presence of the corresponding code within the registry. When medical charts were used as a reference standard, the studies reported different types of descriptions to confirm the presence of disease: Fisher et al [39] reported that "accredited records technicians, blinded to the coding in the original records, reviewed the medical records, selected the supportable diagnoses and procedures, and translated them into ICD-9-CM"; in both the studies conducted by Solin et al [48, 49] and in the study by Leung et al[43] , the diagnosis of carcinoma of the breast was confirmed when there was evidence of a histological documentation of "invasive carcinoma of the breast", "intraductal carcinoma (ductal carcinoma in situ) of the breast" or "Paget's disease of the breast". 4. Page4; line41-46: It would be useful if the authors mention that the usage status of ICD9 and ICD10 codes among each administrative database or/and country. **We reported this information in the results paragraph and in the Table 1 (column "Diagnostic codes"). Between the 21 studies included in our review, 18 studies used ICD-9 codes, and 3 studies (Couris 2009, France; Kemp 2013, Australia; Sato 2015, Japan) used ICD-10 codes. We have added the following sentence in the Results/Study characteristics paragraph: "Eighteen studies9, 32, 33, 35, 36, [38] [39] [40] [41] [42] 44 -51 evaluated ICD-9 codes, and three studies34,37,43 evaluated ICD-10 codes".
Page 5; line9-1:
The primary goal is inconsistent with the conclusions. If the authors had determined the algorithm that accurately identify the breast cancer cases, they should exhibit the algorithm. We modified the objective as follows: "Our objective was to determine the best algorithms with which to identify breast cancer cases using administrative databases based on a comprehensive systematic search of primary studies that validated ICD-9 or ICD-10 codes related to breast cancer." **We modified also the conclusions as follows: "In summary we conclude that, based on the retrieved evidence, administrative databases can be employed to identify primary breast cancer. The best algorithm suggested is ICD-9 or ICD-10 codes located in primary position. Caution should be used when surgical procedures, chemotherapy, radiation therapy, or outpatient data and physician claims are added to the algorithm. We believe that our findings will help researchers that would like to validate breast cancer ICD-9 or ICD-10 codes in administrative databases using either cancer registry or medical charts". 6. Page 7; line21-23: How did the authors detect that the study sample was extracted from general population? For example, if a study conducted using administrative database and reference standard from single medical institution, the generalizability seems low. **Yes, the assumption is true. In each of the included studies, we were able to identify whether all resident women of an area were considered or not. To verify if the study database was from a representative sample of the general population we included only studies that considered all (or a random sample of) the resident women of an area, that could be also a single institution (Sato) or some institutions (Ganry), but representative of the residents of the respective local area or jurisdiction. 7. Page 9-; Result section, Page 13-; Discussion section: In connection with the question6, the generalizability of each study should be mentioned in result and discussion sections. The authors have already shown the information in the Table1, but there are no comprehensive summary and no discussions. I bet that generalizability is important for the authors because they applied it as one of the inclusion criteria of this study. In addition, researchers in this field must be interested in what kind of data sources (e.g., type of databases, type of reference standards, extracted from single institution or multiple institutions) are appropriate to use for a validation study. ** We agree with Dr. Sato regarding generalizability. The following is the paragraph that we added regarding this issue: "Hence, the generalizability of a database is limited to the setting in which the validation has been performed [64] . For example, while Medicare covers the elderly [39, 40, 45, 53, 57, 61] and Medicaid covers indigent and other particular group of patients groups [42, 55] , the U.S. Healthcare, is an independent practice association model, that may represent patient populations of a relatively higher socioeconomic class [48, 49] . Hence, inference from these validated databases cannot be made to those who despite residing in the same area of the residents registered in the above reported systems but do not benefit from them or to subjects age 64 or less as is in most cases of the Medicare system. Conversely, the database in Italy [10, 36] and France [38, 52] where the provision of healthcare is universally provided to residents, the applicability of the results from the validated databases is adequate although it cannot be extended at a national level. Finally, we found a study that validated data from a single institution in Japan and as acknowledged by the authors it is unclear whether the accuracy results can be directly applicable to other hospitals [47] ." 8. Page 11; line17-31; Table 4 : The classification of algorithm in Table 4 seems not appropriate. Of the algorithms in the table 4, part of the algorithms included surgical procedures. The authors divided the algorithm into two categories according to treatment (1. surgical procedures, 2. chemo or radiation therapy). ** Table 3 shows the algorithms of the studies that validated diagnoses of breast cancer and only surgical procedures (without chemo/radiotherapy), while Table 4 shows the results of studies that combined surgical procedures (except in one study) followed by chemo or radiation therapy with diagnosis of breast cancer. We modified the title of Table 4 as follows: "Results of studies that combined surgical procedures followed by chemo or radiation therapy with diagnosis of breast cancer". We modified accordingly also the title of the correspondent paragraph in the result section.
9. Page 11; line52-: It would be useful if the authors mentioned types of data which were used in each of the other 19 studies. Did the 19 studies used only inpatients data or combination of inpatients data and the other data? ** We added this sentence in the text: "…; the other 19 studies considered inpatient data alone or in combination with other types of data (short procedure unit stays, professional services, prescription medicines claims, etc.)". The type of administrative data considered in each study are also shown in Table 1 , column "Type of Administrative Data". 10. Page 12; line10-42: In this section, somehow almost reference papers are omitted. Relevant papers should be exactly cited. ** We have added the references for the cited papers.
11. Page13; line24-8:"The addition of other fields such as surgical procedures, outpatient data and physician claims may improve the accuracy results but depend on the accuracy measure used." I don't believe that the outpatient data and physician claims improved the accuracy of the results because each of the PPVs was too low. What led you to the comments that these data may increase the accuracy? ** We modified the sentence adding chemotherapy and radiation therapy: "The addition of other fields such as surgical procedures, chemotherapy or radiation therapy, outpatient data and physician claims may improve the accuracy results but depend on the accuracy measure used". With this sentence, we want to highlight that, in some circumstances, the addition of these data to the algorithm based solely on diagnostic code could improve the accuracy results. By the addition of surgical procedures, chemotherapy or radiation therapy, the accuracy results are sometimes improved, as shown in Table 3 (see Solin 1994 , Solin 1997 , Leung 1999 , Cooper 1999 and in Table 4 (see Solin 1994 , Solin 1997 , Leung 1999 , Koroukian 2003 , Ganry 2003 , Sato 2015 . By the addition of outpatient data and physician claims, the accuracy results resulted improved only in few cases, as shown in eTable 2: in Freeman 2000, the sensitivity raised from 68% to 95% (primary diagnosis: Physician in the National Claims History file), or to 87% (mammography and laboratory physician); the PPV raised from 74% to 89% (Nodal dissection physician).
